alternative glp-1 medication Compounds: A Cheaper or a Risky Gamble? Compound versions of GLP-1 drugs
Description
Rodrigues, A
2021, Dahl et al
By 2030, the global prevalence of obesity is expected to reach one billion
CNODES, Canadian Network for Observational Drug Effect Studies
doi: 10.1056/NEJMoa1812389 9 MosenzonOWiviottSDCahnARozenbergAYanuvIGoodrichELet al
The once-daily Wegovy pill (semaglutide) was approved for weight loss and weight maintenance in adults who are overweight or have obesity and at least one related health problem, drugmaker Novo Nordisk said in a statement
